Global Pediatric Vaccine Market Is Expected To Reach Around USD 56.28 Billion By 2025

09-Aug-2019 | Zion Market Research

Zion Market Research has published a new report titled “Pediatric Vaccine Market By Vaccine Type (Monovalent and Multivalent), By Administration Method (Oral, Intramuscular, and Subcutaneous), By Disease Type (Meningococcal Disease, Hepatitis, Influenza, Polio, Pneumococcal Disease, DTP, MMR, Dengue, Rotavirus, HPV, Varicella, Herpes Zoster, and Others), By Technology (Recombinant Vaccines, Inactivated Vaccines, Conjugate Vaccines, Toxoid Vaccines, and Live Attenuated Vaccines), and By End-User (Hospitals, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global pediatric vaccine market was approximately USD 27.45 billion in 2018 and is expected to generate around USD 56.28 billion by 2025, at a CAGR of around 10.8% between 2019 and 2025.

Pediatric vaccines protect children from complications and serious illnesses, which could lead to paralysis, brain damage, amputations, and even death. The growing prevalence of preventable diseases occurs when parents do not administer vaccinations on a timely basis. Organizations like the American Academy of Family Physicians, the American Academy of Pediatrics, and the Centers for Disease Control and Prevention administer the regulations and schedules for recommended vaccinations. Vaccine-preventable diseases, such as whooping cough, measles, and mumps, affect millions of children globally and can even lead to deaths, long-term hospitalizations, and severe paralysis if left untreated. The immune system, which is composed of organs, cells, fluids, and glands, recognizes the germs, called antigens, and produces large Y-shaped proteins called antibodies to fight them. For example, mumps vaccine contains the mumps virus. The antigens in these vaccines are either weakened or killed, to prevent the disease from infecting the body further. The global pediatric vaccine market is driven by increasing geriatric base, rising prevalence of infectious diseases, and growing disposable income of the global population. The rising number of immunization programs globally and the increasing awareness about the importance of preventive care during childhood are also fuelling this market.

Browse the full “Pediatric Vaccine Market By Vaccine Type (Monovalent and Multivalent), By Administration Method (Oral, Intramuscular, and Subcutaneous), By Disease Type (Meningococcal Disease, Hepatitis, Influenza, Polio, Pneumococcal Disease, DTP, MMR, Dengue, Rotavirus, HPV, Varicella, Herpes Zoster, and Others), By Technology (Recombinant Vaccines, Inactivated Vaccines, Conjugate Vaccines, Toxoid Vaccines, and Live Attenuated Vaccines), and By End-User (Hospitals, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/pediatric-vaccine-market

Global Pediatric Vaccine Market

The global pediatric vaccine market is divided based on disease type, vaccine type, administration method, technology, and end-user. By vaccine type, the market includes monovalent and multivalent vaccines. Monovalent vaccines develop a rapid immune response and are more stable than multivalent vaccines. Multivalent vaccines are showing improved growth due to the development of tetravalent, hexavalent, and pentavalent vaccines. Based on technology,  the market comprises recombinant vaccines, inactivated vaccines, conjugate vaccines, toxoid vaccines, and live attenuated vaccines. Conjugate vaccines have the maximum demand, due to the rising incidences of meningococcal and pneumococcal infections. The disease type segment consists of dengue, pneumococcal disease, hepatitis, MMR (measles, mumps, and rubella), varicella, polio, influenza, DTP, herpes zoster, rotavirus, human papilloma virus, meningococcal disease, and others. The method segment of the pediatric vaccine market includes oral, subcutaneous, and intramuscular. Hospitals, healthcare providers, and others are the various end-user of the pediatric vaccine market.

North America is witnessed to be a significant contributor to the pediatric vaccine market globally, due to the increasing number of hospitals, developing insurance sector, and favorable government regulations. The European pediatric vaccine market is growing owing to the ease of operability, efficient resource planning, presence of a large number of pharmaceutical companies, and rising government funding. All this makes facilitates quick and easy sourcing of vaccines. The Asia Pacific pediatric vaccine market will register the highest CAGR in the future, owing to the rapidly growing pediatric vaccine demand in India and Singapore. Latin America is projected to exhibit moderate growth in the pediatric vaccine market over the forecast timeframe.

Some key players operating in the global pediatric vaccine market are Mitsubishi Tanabe Pharma, Astellas Pharma, Johnson & Johnson, Pfizer, CSL Limited, GlaxoSmithKline, Serum Institute of India, Panacea Biotec, Daiichi Sankyo, and Merck.

This report segment the global pediatric vaccine market into:

Global Pediatric Vaccine Market: By Vaccine Type

  • Monovalent Vaccines
  • Multivalent Vaccines

Global Pediatric Vaccine Market: By Disease Type

  • Meningococcal Disease
  • Hepatitis
  • Influenza
  • Polio
  • Pneumococcal Disease
  • DTP
  • MMR (Measles, Mumps, and Rubella)
  • Dengue
  • Rotavirus
  • Human Papilloma Virus (HPV)
  • Varicella
  • Herpes Zoster
  • Others

Global Pediatric Vaccine Market: By Technology

  • Recombinant Vaccines
  • Inactivated Vaccines
  • Conjugate Vaccines
  • Toxoid Vaccines
  • Live Attenuated Vaccines

Global Pediatric Vaccine Market: By Administration Method

  • Oral
  • Intramuscular
  • Subcutaneous

Global Pediatric Vaccine Market: By End-User

  • Hospitals
  • Healthcare Providers
  • Others

Global Pediatric Vaccine Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed